论文部分内容阅读
目的:探究通过垂体后叶素联合酚妥拉明有效治疗支气管扩张咯血的临床效果。方法选取2013年3月到2014年3月来我院就诊的54例患者随机分为观察组与对照组,观察组患者给予药物垂体后叶素与酚妥拉明治疗,对照组患者仅给予垂体后叶素治疗,对比用药后效果。结果观察组患者各方面情况由于对照组(P<0.05)。结论垂体后叶素联合酚妥拉明在有效治疗支气管扩张咯血方面效果显著,安全、科学,患者的疾病治愈率高,病死率低,不良反应少,可在临床进一步推广使用。
Objective: To investigate the clinical effect of pituitrin combined with phentolamine in the treatment of bronchiectasis hemoptysis. Methods 54 patients from our hospital from March 2013 to March 2014 were randomly divided into observation group and control group. Patients in observation group were treated with pituitrin and phentolamine, while those in control group were given only pituitary Vasopressin treatment, after the effect of medication. Results The observation group patients in all aspects due to the control group (P <0.05). Conclusion Pituitrin combined with phentolamine in the effective treatment of bronchiectasis hemoptysis significant effect, safety, science, patients with high cure rate, low mortality, fewer adverse reactions, can be further promoted in clinical use.